Apollo Healthcare Corp
TSX:AHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lululemon Athletica Inc
NASDAQ:LULU
|
CA |
Apollo Healthcare Corp
Research & Development
Apollo Healthcare Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Apollo Healthcare Corp
TSX:AHC
|
Research & Development
-CA$1m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Flora Growth Corp
NASDAQ:FLGC
|
Research & Development
-$418k
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-84%
|
CAGR 10-Years
N/A
|
|
|
Genix Pharmaceuticals Corp
XTSX:GENX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitality Products Inc
XTSX:VPI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jamieson Wellness Inc
TSX:JWEL
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
L
|
Leef Brands Inc
CNSX:LEEF
|
Research & Development
-$23k
|
CAGR 3-Years
72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Apollo Healthcare Corp
Glance View
Apollo Healthcare Corp. engages in manufacturing and developing private label personal care products and retailer-branded products for North American retailers. The company is headquartered in Toronto, Ontario and currently employs 500 full-time employees. The company went IPO on 2015-09-08. The firm is engaged in developing and manufacturing retailer branded and private label products for North American retailers. The firm operates through private label consumer staples business segment. The Company’s products are sold in stores across North America and serves North American grocery, drug, and mass merchandise retailers, as well as wholesale clubs. Along with private label, the Company also manufactures products on a contract basis for its clients.
See Also
What is Apollo Healthcare Corp's Research & Development?
Research & Development
-1m
CAD
Based on the financial report for Dec 31, 2020, Apollo Healthcare Corp's Research & Development amounts to -1m CAD.
What is Apollo Healthcare Corp's Research & Development growth rate?
Research & Development CAGR 3Y
22%
Over the last year, the Research & Development growth was 9%. The average annual Research & Development growth rates for Apollo Healthcare Corp have been 22% over the past three years .